Koschinsky to lead Robarts Research Institute

Marlys Koschinsky, current dean of the Faculty of Science at the University of Windsor, has been named the new Scientific and Executive Director at Robarts Research Institute.

Koschinsky, who received her PhD in Biochemistry from the University of British Columbia, brings an extensive research career with her to Robarts. She begins her new role Oct. 1.

Koschinsky 2

 

Completing a Medical Research Council of Canada postdoctoral fellowship at Genentech Inc., a biotechnology company in South San Francisco, in 1991, Koschinsky spent the next 17 years as Director of the Cardiac, Circulatory & Respiratory Research Program and Acting Head of the Department of Physiology at Queen’s University, before heading to the University of Windsor in 2008.

Her research is in the areas of atherosclerosis and thrombosis, focusing on the understanding of mechanisms of risk factors for cardiovascular disease. She is an internationally recognized expert in the study of lipoprotein(a) – a genetic risk factor for cardiovascular disease – and is a well-respected opinion leader in the area of lipoproteins and cardiovascular disease.

“It is a tremendous pleasure to welcome Marlys to the Schulich School of Medicine & Dentistry,” said Schulich Dean Dr. Michael Strong. “She brings to the Institute a highly respected and successful research career, proven leadership skills, and a thorough understanding of the Canadian research milieu.”

Koschinsky shows a strong commitment to community engagement as well, being involved with a number of organizations in Windsor. She is the Vice-Chair of the Board of Directors for WEtech Alliance, a senior leadership volunteer with the Heart and Stroke Foundation; Chair of the Windsor-Essex Mission Committee; and has served as a member of the Windsor-Essex Economic Development Corporation’s Life and Health Sciences Task Force. She is also a member of the steering committee for the South West Academic Health Network.